Understanding uveitis in a multi-system disease model of spondyloarthropathy

了解脊柱关节病多系统疾病模型中的葡萄膜炎

基本信息

  • 批准号:
    8534131
  • 负责人:
  • 金额:
    $ 36.58万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-09-30 至 2015-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Spondyloarthropathies (SpAs) are chronic, immune-mediated, inflammatory disorders, of which ankylosing spondylitis (AS) is the most common. On average SpA affects ~1% of the general human population. Uveitis is a frequent extra-articular organ afflicted in such diseases. Indeed AS-associated uveitis is the most frequently observed type of uveitis in patients. Yet, the pathogenesis of uveitis is poorly understood in part due to a current lack of experimental models. We have recently discovered that uveitis occurs in an established mouse model of proteoglycan-induced arthritis (PGIA), wherein experimental immunity to the cartilage proteoglycan results in progressive polyarthrits and spondylitis. To our knowledge this is the first murine model of disease that will allow us to study the eye's susceptibility to disease in presence of arthritis and spondylitis as occurs clinically in patients. Moreover, our data support different ongoing mechanisms of disease in the eye versus joint and spine as deficiency in the Th1-related cytokine, IFNg, markedly exacerbates uveitis but diminishes the severity of arthritis and spondylitis. Th17 response appears to play a dominant role in uveitis in the absence of IFNg. These observations could have a huge impact on how we treat uveitis in a multi-system disease. The studies proposed here will inform us about mechanisms involved in the uveitis aspect of disease and will be important to our understanding of SpA development as well. We propose to identify the function of T cell effector responses in the pathogenesis of uveitis and define how they relate to joint and spine disease. We will determine whether mechanisms of the eye can be distinguished from the joint and spine and will explore the regulatory role for IFNg in controlling the eye's sensitivity to disease and Th17 response. We will explore how therapeutic intervention affects specific organs. This model will be a valuable tool for discovery of mechanisms controlling eye disease as it relates to systemic form of disease and will have considerable implications for understanding SpA pathogenesis as well.
描述(由申请人提供):脊柱关节病(SpA)是一种慢性、免疫介导的炎症性疾病,其中强直性脊柱炎(AS)最为常见。平均而言,SpA影响约1%的一般人群。葡萄膜炎是此类疾病中常见的关节外器官。事实上,AS相关性葡萄膜炎是患者中最常见的葡萄膜炎类型。然而,葡萄膜炎的发病机制知之甚少,部分原因是目前缺乏实验模型。我们最近发现,葡萄膜炎发生在蛋白聚糖诱导的关节炎(PGIA)的小鼠模型中,其中对软骨蛋白聚糖的实验性免疫导致进行性多关节炎和脊柱炎。据我们所知,这是第一个小鼠疾病模型,将使我们能够研究眼睛的疾病的易感性,在关节炎和脊柱炎的存在下,临床上发生在患者。此外,我们的数据支持眼睛与关节和脊柱中疾病的不同持续机制,因为Th1相关细胞因子IFNg的缺乏显著加重葡萄膜炎,但减轻关节炎和脊柱炎的严重程度。在IFNg不存在的情况下,Th17应答似乎在葡萄膜炎中起主导作用。这些观察结果可能对我们如何治疗多系统疾病中的葡萄膜炎产生巨大影响。这里提出的研究将告知我们葡萄膜炎方面的疾病的机制,并将是重要的,我们了解的SpA的发展以及。我们建议确定T细胞效应反应在葡萄膜炎发病机制中的作用,并确定它们与关节和脊柱疾病的关系。我们将确定眼睛的机制是否可以与关节和脊柱区分开来,并将探索IFNg在控制眼睛对疾病的敏感性和Th17反应中的调节作用。我们将探讨治疗干预如何影响特定器官。这个模型将是一个有价值的工具,发现控制眼病的机制,因为它涉及到系统性形式的疾病,并将有相当大的影响,了解SpA的发病机制以及。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JAMES T ROSENBAUM其他文献

JAMES T ROSENBAUM的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JAMES T ROSENBAUM', 18)}}的其他基金

The Gut Microbiome and HLA B27-associated Acute Anterior Uveitis
肠道微生物组和 HLA B27 相关的急性前葡萄膜炎
  • 批准号:
    10228030
  • 财政年份:
    2018
  • 资助金额:
    $ 36.58万
  • 项目类别:
Characterizing Uveitis by Gene Expression
通过基因表达表征葡萄膜炎
  • 批准号:
    9235011
  • 财政年份:
    2017
  • 资助金额:
    $ 36.58万
  • 项目类别:
Gene Expression in Nonspecific Orbital Inflammatory Disease
非特异性眼眶炎症性疾病中的基因表达
  • 批准号:
    8547813
  • 财政年份:
    2011
  • 资助金额:
    $ 36.58万
  • 项目类别:
Understanding uveitis in a multi-system disease model of spondyloarthropathy
了解脊柱关节病多系统疾病模型中的葡萄膜炎
  • 批准号:
    8153482
  • 财政年份:
    2011
  • 资助金额:
    $ 36.58万
  • 项目类别:
Understanding uveitis in a multi-system disease model of spondyloarthropathy
了解脊柱关节病多系统疾病模型中的葡萄膜炎
  • 批准号:
    8328922
  • 财政年份:
    2011
  • 资助金额:
    $ 36.58万
  • 项目类别:
Gene Expression in Nonspecific Orbital Inflammatory Disease
非特异性眼眶炎症性疾病中的基因表达
  • 批准号:
    8206876
  • 财政年份:
    2011
  • 资助金额:
    $ 36.58万
  • 项目类别:
Gene Expression in Nonspecific Orbital Inflammatory Disease
非特异性眼眶炎症性疾病中的基因表达
  • 批准号:
    8726404
  • 财政年份:
    2011
  • 资助金额:
    $ 36.58万
  • 项目类别:
Gene Expression in Nonspecific Orbital Inflammatory Disease
非特异性眼眶炎症性疾病中的基因表达
  • 批准号:
    10016308
  • 财政年份:
    2011
  • 资助金额:
    $ 36.58万
  • 项目类别:
Gene Expression in Nonspecific Orbital Inflammatory Disease
非特异性眼眶炎症性疾病中的基因表达
  • 批准号:
    8328921
  • 财政年份:
    2011
  • 资助金额:
    $ 36.58万
  • 项目类别:
Gene Expression in Nonspecific Orbital Inflammatory Disease
非特异性眼眶炎症性疾病中的基因表达
  • 批准号:
    9769746
  • 财政年份:
    2011
  • 资助金额:
    $ 36.58万
  • 项目类别:

相似海外基金

Dysregulation of Cytotoxic T Cell Exhaustion in Ankylosing Spondylitis
强直性脊柱炎中细胞毒性 T 细胞耗竭的失调
  • 批准号:
    488673
  • 财政年份:
    2023
  • 资助金额:
    $ 36.58万
  • 项目类别:
    Operating Grants
Investigating the Role of T cell surface sialoglycans in Ankylosing spondylitis immunopathogenesis
研究 T 细胞表面唾液酸聚糖在强直性脊柱炎免疫发病机制中的作用
  • 批准号:
    486602
  • 财政年份:
    2022
  • 资助金额:
    $ 36.58万
  • 项目类别:
    Studentship Programs
Prospective Evaluation of Autoimmune Ear Disease in Ankylosing Spondylitis & Spondyloarthritis
强直性脊柱炎自身免疫性耳病的前瞻性评估
  • 批准号:
    450958
  • 财政年份:
    2020
  • 资助金额:
    $ 36.58万
  • 项目类别:
    Studentship Programs
T cell trafficking and specificity in ankylosing spondylitis
强直性脊柱炎中的 T 细胞运输和特异性
  • 批准号:
    380299
  • 财政年份:
    2018
  • 资助金额:
    $ 36.58万
  • 项目类别:
    Operating Grants
Identification of disease-related T cell clones and arthritogenic antigens in ankylosing spondylitis
强直性脊柱炎疾病相关 T 细胞克隆和致关节炎抗原的鉴定
  • 批准号:
    413277889
  • 财政年份:
    2018
  • 资助金额:
    $ 36.58万
  • 项目类别:
    Research Grants
Macrophage migration inhibitory factor (MIF) as a Crucial Regulatory Cytokine and Therapeutic Target in Ankylosing Spondylitis
巨噬细胞迁移抑制因子(MIF)作为强直性脊柱炎的关键调节细胞因子和治疗靶点
  • 批准号:
    397552
  • 财政年份:
    2018
  • 资助金额:
    $ 36.58万
  • 项目类别:
    Fellowship Programs
Solving the causes of and development of new therapies for ankylosing spondylitis and related diseases
解决强直性脊柱炎及相关疾病的病因并开发新疗法
  • 批准号:
    nhmrc : GNT1118005
  • 财政年份:
    2017
  • 资助金额:
    $ 36.58万
  • 项目类别:
    Research Fellowships
Solving the causes of and development of new therapies for ankylosing spondylitis and related diseases
解决强直性脊柱炎及相关疾病的病因并开发新疗法
  • 批准号:
    nhmrc : 1118005
  • 财政年份:
    2017
  • 资助金额:
    $ 36.58万
  • 项目类别:
    Research Fellowships
Personalized medicine for ankylosing spondylitis
强直性脊柱炎个体化用药
  • 批准号:
    365355
  • 财政年份:
    2017
  • 资助金额:
    $ 36.58万
  • 项目类别:
    Operating Grants
Development and application of a Mendelian randomization framework aimed at dissecting the biological basis of ankylosing spondylitis and other complex diseases
孟德尔随机化框架的开发和应用,旨在剖析强直性脊柱炎和其他复杂疾病的生物学基础
  • 批准号:
    nhmrc : GNT1125200
  • 财政年份:
    2017
  • 资助金额:
    $ 36.58万
  • 项目类别:
    Project Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了